Bacchus Bio innovation Co., Ltd.<\/p>\r\n
<\/p>\r\n
Changes in Executive personnel<\/p>\r\n
<\/p>\r\n
\u3000We would like to inform you that we have made the following changes to the executive personnel. This matter is scheduled to be formally decided at the annual general meeting of shareholders and the board of directors meeting scheduled to be held on March 29, 2024.<\/p>\r\n
<\/p>\r\n
\uff08\uff11\uff09Change details<\/p>\r\n
| \r\n New role<\/p>\r\n<\/td>\r\n | \r\n Name<\/p>\r\n<\/td>\r\n | \r\n Current role<\/p>\r\n<\/td>\r\n<\/tr>\r\n | ||||||||||||||
| \r\n Representative Director and CEO<\/p>\r\n<\/td>\r\n | \r\n Akihiko Kondo<\/p>\r\n<\/td>\r\n | \r\n Director<\/p>\r\n<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n \u203bThe current President, Mikio Tanji, will retire from the position of the President and will act as director effective from March 29, 2024.<\/p>\r\n \u00a0<\/span><\/p>\r\n \uff08\uff12\uff09Reason for change<\/p>\r\n \u3000The recent executive appointment changes involve our founder and director, Akihiko Kondo, focusing more on the technical development of various projects and dedicating himself even further to our company's business. This is in line with our medium to long-term strategy aimed at achieving sustainable growth and enhancing our corporate value.<\/p>\r\n \u00a0<\/span><\/p>\r\n Name<\/p>\r\n<\/td>\r\n Current role (As of March 1, 2024)<\/p>\r\n<\/td>\r\n<\/tr>\r\n Geroge Hara<\/p>\r\n<\/td>\r\n Chairman<\/p>\r\n<\/td>\r\n<\/tr>\r\n Mikio Tanji<\/p>\r\n<\/td>\r\n President<\/p>\r\n<\/td>\r\n<\/tr>\r\n Makoto Hattori<\/p>\r\n<\/td>\r\n Director<\/p>\r\n<\/td>\r\n<\/tr>\r\n Akihiko Kondo<\/p>\r\n<\/td>\r\n Director<\/p>\r\n<\/td>\r\n<\/tr>\r\n Kunio Yamada<\/p>\r\n<\/td>\r\n External director<\/p>\r\n<\/td>\r\n<\/tr>\r\n Norio Yamakawa<\/p>\r\n<\/td>\r\n External director<\/p>\r\n<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n \u00a0<\/span><\/p>\r\n \uff0a\uff0a\uff0a\uff0aDirect your enquiries to\uff0a\uff0a\uff0a\uff0a<\/p>\r\n Bacchus Bio innovation Co., Ltd.<\/p>\r\n Management and Public Relations E-mail\uff1ainfo@b2i.co.jp<\/p>\r\n <\/p>","protected":false},"excerpt":{"rendered":"Bacchus Bio innovation Co., Ltd. Changes in Executive personnel \u3000We would like to inform you tha ...","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_locale":"en_US","_original_post":"https:\/\/www.b2i.co.jp\/?p=411","footnotes":""},"categories":[1],"tags":[],"class_list":["post-625","post","type-post","status-publish","format-standard","hentry","category-news","en-US"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/posts\/625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/comments?post=625"}],"version-history":[{"count":13,"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/posts\/625\/revisions"}],"predecessor-version":[{"id":638,"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/posts\/625\/revisions\/638"}],"wp:attachment":[{"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/media?parent=625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/categories?post=625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.b2i.co.jp\/wp-json\/wp\/v2\/tags?post=625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} |